National Post: “A team of Canadian and U.S. researchers has developed a new “sharp-shooter” drug they hope may be a breakthrough in treating several types of aggressive cancer.” Known as “CFI-400945”, this drug targets a specific enzyme found in certain types of breast, ovarian, colorectal, pancreatic and prostate cancer. These results are only from tests …
Read more »